Annual FCF:
$171.23M+$60.69M(+54.91%)Summary
- As of today, SUPN annual free cash flow is $171.23 million, with the most recent change of +$60.69 million (+54.91%) on December 31, 2024.
- During the last 3 years, SUPN annual free cash flow has risen by +$46.14 million (+36.89%).
- SUPN annual free cash flow is now at all-time high.
Performance
SUPN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$58.08M+$27.81M(+91.86%)Summary
- As of today, SUPN quarterly free cash flow is $58.08 million, with the most recent change of +$27.81 million (+91.86%) on June 30, 2025.
- Over the past year, SUPN quarterly free cash flow has increased by +$22.52 million (+63.33%).
- SUPN quarterly free cash flow is now -36.45% below its all-time high of $91.39 million, reached on June 30, 2020.
Performance
SUPN Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$185.87M+$22.52M(+13.79%)Summary
- As of today, SUPN TTM free cash flow is $185.87 million, with the most recent change of +$22.52 million (+13.79%) on June 30, 2025.
- Over the past year, SUPN TTM free cash flow has increased by +$31.43 million (+20.35%).
- SUPN TTM free cash flow is now at all-time high.
Performance
SUPN TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SUPN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +54.9% | +63.3% | +20.4% |
| 3Y3 Years | +36.9% | -19.0% | +55.3% |
| 5Y5 Years | +20.8% | -36.5% | +28.3% |
SUPN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +54.9% | at high | +405.1% | at high | +161.5% |
| 5Y | 5-Year | at high | +54.9% | -19.0% | +405.1% | at high | +161.5% |
| All-Time | All-Time | at high | +387.3% | -36.5% | +384.4% | at high | +380.4% |
SUPN Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $58.08M(+91.9%) | $185.87M(+13.8%) |
| Mar 2025 | - | $30.27M(-31.5%) | $163.34M(-4.6%) |
| Dec 2024 | $171.23M(+54.9%) | $44.19M(-17.1%) | $171.23M(-0.5%) |
| Sep 2024 | - | $53.32M(+49.9%) | $172.03M(+11.4%) |
| Jun 2024 | - | $35.56M(-6.8%) | $154.43M(+54.7%) |
| Mar 2024 | - | $38.15M(-15.2%) | $99.84M(-9.7%) |
| Dec 2023 | $110.53M(-5.1%) | $44.99M(+25.9%) | $110.53M(+18.7%) |
| Sep 2023 | - | $35.73M(+287.7%) | $93.11M(+31.0%) |
| Jun 2023 | - | -$19.03M(-139.0%) | $71.08M(-56.1%) |
| Mar 2023 | - | $48.85M(+77.2%) | $161.81M(+39.0%) |
| Dec 2022 | $116.41M(-6.9%) | $27.57M(+101.4%) | $116.41M(-15.4%) |
| Sep 2022 | - | $13.69M(-80.9%) | $137.56M(+14.9%) |
| Jun 2022 | - | $71.69M(+1977.5%) | $119.72M(+27.0%) |
| Mar 2022 | - | $3.45M(-92.9%) | $94.29M(-24.6%) |
| Dec 2021 | $125.08M(-7.1%) | $48.72M(+1272.9%) | $125.08M(+15.8%) |
| Sep 2021 | - | -$4.15M(-109.0%) | $107.98M(-8.1%) |
| Jun 2021 | - | $46.27M(+35.1%) | $117.45M(-27.8%) |
| Mar 2021 | - | $34.24M(+8.3%) | $162.57M(+20.7%) |
| Dec 2020 | $134.71M(-5.0%) | $31.62M(+494.3%) | $134.71M(-7.0%) |
| Sep 2020 | - | $5.32M(-94.2%) | $144.85M(-18.0%) |
| Jun 2020 | - | $91.39M(+1332.7%) | $176.73M(+55.0%) |
| Mar 2020 | - | $6.38M(-84.7%) | $114.00M(-18.8%) |
| Dec 2019 | $141.74M(+10.6%) | $41.76M(+12.3%) | $140.39M(+7.0%) |
| Sep 2019 | - | $37.20M(+29.8%) | $131.25M(-15.9%) |
| Jun 2019 | - | $28.66M(-12.5%) | $156.04M(+16.8%) |
| Mar 2019 | - | $32.77M(+0.5%) | $133.57M(+4.9%) |
| Dec 2018 | $128.14M(+13.8%) | $32.62M(-47.4%) | $127.33M(-1.5%) |
| Sep 2018 | - | $61.98M(+900.6%) | $129.26M(+23.2%) |
| Jun 2018 | - | $6.19M(-76.7%) | $104.96M(-11.3%) |
| Mar 2018 | - | $26.54M(-23.2%) | $118.34M(+16.6%) |
| Dec 2017 | $112.61M | $34.55M(-8.3%) | $101.46M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $37.68M(+92.5%) | $84.94M(+27.6%) |
| Jun 2017 | - | $19.57M(+102.8%) | $66.57M(+11.1%) |
| Mar 2017 | - | $9.65M(-46.5%) | $59.90M(+29.1%) |
| Dec 2016 | $65.21M(+101.1%) | $18.04M(-6.5%) | $46.39M(+6.9%) |
| Sep 2016 | - | $19.30M(+49.6%) | $43.41M(+93.5%) |
| Jun 2016 | - | $12.90M(+434.5%) | $22.44M(+13.3%) |
| Mar 2016 | - | -$3.86M(-125.6%) | $19.80M(-7.9%) |
| Dec 2015 | $32.42M(+229.2%) | $15.06M(+1003.1%) | $21.51M(+79.7%) |
| Sep 2015 | - | -$1.67M(-116.2%) | $11.97M(-69.5%) |
| Jun 2015 | - | $10.27M(+577.7%) | $39.22M(+87.6%) |
| Mar 2015 | - | -$2.15M(-138.9%) | $20.91M(+693.5%) |
| Dec 2014 | -$25.09M(+57.9%) | $5.52M(-78.4%) | $2.63M(+120.4%) |
| Sep 2014 | - | $25.58M(+418.1%) | -$12.94M(+76.2%) |
| Jun 2014 | - | -$8.04M(+60.6%) | -$54.44M(+13.3%) |
| Mar 2014 | - | -$20.42M(-103.2%) | -$62.82M(-4.7%) |
| Dec 2013 | -$59.59M(-24.3%) | -$10.05M(+36.9%) | -$59.99M(+9.5%) |
| Sep 2013 | - | -$15.93M(+3.0%) | -$66.28M(-6.8%) |
| Jun 2013 | - | -$16.42M(+6.7%) | -$62.05M(-11.9%) |
| Mar 2013 | - | -$17.59M(-7.7%) | -$55.44M(-15.6%) |
| Dec 2012 | -$47.95M(-30.1%) | -$16.34M(-39.7%) | -$47.95M(-19.7%) |
| Sep 2012 | - | -$11.70M(-19.2%) | -$40.06M(-6.7%) |
| Jun 2012 | - | -$9.81M(+3.0%) | -$37.55M(-1.5%) |
| Mar 2012 | - | -$10.11M(-19.6%) | -$36.97M(-0.3%) |
| Dec 2011 | -$36.87M(-12.3%) | -$8.45M(+8.0%) | -$36.87M(-29.7%) |
| Sep 2011 | - | -$9.18M(+0.6%) | -$28.42M(-47.7%) |
| Jun 2011 | - | -$9.24M(+7.7%) | -$19.24M(-92.3%) |
| Mar 2011 | - | -$10.00M | -$10.00M |
| Dec 2010 | -$32.84M(-1810.3%) | - | - |
| Dec 2009 | $1.92M(+106.4%) | - | - |
| Dec 2008 | -$29.79M(-98.0%) | - | - |
| Dec 2007 | -$15.04M | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of SUPN is $171.23M
What is the all-time high annual free cash flow for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual free cash flow is $171.23M
What is Supernus Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, SUPN annual free cash flow has changed by +$60.69M (+54.91%)
What is Supernus Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of SUPN is $58.08M
What is the all-time high quarterly free cash flow for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly free cash flow is $91.39M
What is Supernus Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, SUPN quarterly free cash flow has changed by +$22.52M (+63.33%)
What is Supernus Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of SUPN is $185.87M
What is the all-time high TTM free cash flow for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM free cash flow is $185.87M
What is Supernus Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, SUPN TTM free cash flow has changed by +$31.43M (+20.35%)